Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67 USD | +2.57% | +1.96% | -6.45% |
May. 16 | Transcript : Intra-Cellular Therapies, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM | |
May. 07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
Financials (USD)
Sales 2024 * | 663M | Sales 2025 * | 924M | Capitalization | 6.9B |
---|---|---|---|---|---|
Net income 2024 * | -56M | Net income 2025 * | 111M | EV / Sales 2024 * | 9.09 x |
Net cash position 2024 * | 872M | Net cash position 2025 * | 926M | EV / Sales 2025 * | 6.46 x |
P/E ratio 2024 * |
-116
x | P/E ratio 2025 * |
59.8
x | Employees | 610 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.68% |
Latest transcript on Intra-Cellular Therapies, Inc.
1 day | +2.57% | ||
1 week | +1.96% | ||
Current month | -6.70% | ||
1 month | -7.42% | ||
3 months | -8.57% | ||
6 months | +14.47% | ||
Current year | -6.45% |
Managers | Title | Age | Since |
---|---|---|---|
Sharon Mates
CEO | Chief Executive Officer | 71 | 13-08-28 |
Director of Finance/CFO | 67 | 13-08-28 | |
Michael Halstead
PSD | President | 51 | 14-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
BRD | Director/Board Member | 71 | 14-01-07 |
Joel Marcus
BRD | Director/Board Member | 76 | 13-08-28 |
Director/Board Member | 67 | 14-01-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.14% | 14 M€ | -2.76% | ||
0.45% | 0 M€ | 0.00% | - | |
0.40% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 67 | +2.57% | 941,795 |
24-05-20 | 65.32 | +0.49% | 999,099 |
24-05-17 | 65 | -2.30% | 783,425 |
24-05-16 | 66.53 | -0.46% | 723,533 |
24-05-15 | 66.84 | +1.72% | 691,551 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.45% | 6.9B | |
-2.46% | 89.69B | |
+2.50% | 41.34B | |
-12.01% | 33.72B | |
+62.74% | 26.11B | |
-19.79% | 14.63B | |
-8.58% | 12.84B | |
-12.34% | 11.66B | |
-43.92% | 11.52B | |
+4.27% | 8.92B |
- Stock Market
- Equities
- ITCI Stock